Page last updated: 2024-08-21

quinazolines and Adrenocortical Carcinoma

quinazolines has been researched along with Adrenocortical Carcinoma in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Li, H; Ma, C; Su, H; Xiong, J	1
Antonini, SR; Borges, KS; Brandalise, SR; Cardinalli, I; de Castro, M; Martinelli, CE; Mastellaro, MJ; Moreno, DA; Neder, L; Ramalho, LN; Scrideli, CA; Seidinger, AL; Tone, LG; Tucci, S; Yunes, JA	1
Bertele', V; Garattini, S; Gerardi, C; Joppi, R	1
Adam, P; Allolio, B; Fassnacht, M; Hahner, S; Johanssen, S; Quinkler, M; Ritte, C; Ritter, C; Strasburger, C; Wortmann, S	1

Reviews

1 review(s) available for quinazolines and Adrenocortical Carcinoma

Article	Year
Letting post-marketing bridge the evidence gap: the case of orphan drugs. BMJ (Clinical research ed.), 2016, Jun-22, Volume: 353 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate	2016

Article

Year

Letting post-marketing bridge the evidence gap: the case of orphan drugs.

BMJ (Clinical research ed.), 2016, Jun-22, Volume: 353

Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate

2016

Trials

1 trial(s) available for quinazolines and Adrenocortical Carcinoma

Article	Year
Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:6 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Drug Administration Routes; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Quinazolines; Salvage Therapy; Treatment Outcome	2008

Article

Year

Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine.

The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:6

Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Drug Administration Routes; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Quinazolines; Salvage Therapy; Treatment Outcome

2008

Other Studies

2 other study(ies) available for quinazolines and Adrenocortical Carcinoma

Article	Year
The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma. International journal of medical sciences, 2021, Volume: 18, Issue:13 Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Biomarkers, Tumor; Chemotherapy, Adjuvant; Computational Biology; Databases, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Isoquinolines; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Prognosis; Protein Kinase Inhibitors; Quinazolines; RNA-Seq; RNA, Messenger; Succinimides; Sulfonamides	2021
Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis. Pediatric blood & cancer, 2013, Volume: 60, Issue:11 Topics: Adolescent; Adrenocortical Carcinoma; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Benzamides; Cell Proliferation; Cells, Cultured; Child; Child, Preschool; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Immunohistochemistry; Infant; Kaplan-Meier Estimate; M Phase Cell Cycle Checkpoints; Male; Prognosis; Proportional Hazards Models; Protein Serine-Threonine Kinases; Quinazolines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transcriptome	2013

Article

Year

The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.

International journal of medical sciences, 2021, Volume: 18, Issue:13

Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Biomarkers, Tumor; Chemotherapy, Adjuvant; Computational Biology; Databases, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Isoquinolines; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Prognosis; Protein Kinase Inhibitors; Quinazolines; RNA-Seq; RNA, Messenger; Succinimides; Sulfonamides

2021

Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis.

Pediatric blood & cancer, 2013, Volume: 60, Issue:11

Topics: Adolescent; Adrenocortical Carcinoma; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Benzamides; Cell Proliferation; Cells, Cultured; Child; Child, Preschool; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Immunohistochemistry; Infant; Kaplan-Meier Estimate; M Phase Cell Cycle Checkpoints; Male; Prognosis; Proportional Hazards Models; Protein Serine-Threonine Kinases; Quinazolines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transcriptome

2013